There is often talk of whether (or when) resistance to praziquantel will develop, and how catastrophic this would be for the treatment of schisto. There have been some important studies on this over the years, but a recent paper in PLoS NTD provides some new evidence for the development of resistance in Kenya. Thanks to Marc for the heads up.